[Abstract] Directed deletion mutants in non-typeable Haemophilus influenzae can be made by allelic exchange of the target gene with an artificial DNA construct in which an antibiotic resistance cassette is placed between two ~1,000 bp DNA sequences that are identical to the 5' and 3' flanking regions of the target gene. The artificial DNA construct that is required for this mutagenesis is synthesized by the so-called Megaprimer PCR method (Figure 1 ). The L2 and R2 primers have extensions with homology to the antibiotic resistance cassette.
2. Purify PCR products with QIAquick PCR Purification Kit.
3. Measure DNA concentration with the Nanodrop. Concentration of >20 ng/μl is enough for the Megaprimer PCR (step 6).
4.
Load 2 μl PCR product mixed with DNA loading buffer on a 1.5% agarose gel with a 100 bp DNA marker.
5. Check the gel for purity (should be a single PCR product) and size of the product (size depends on the primer design, usually ~1,000 bp). When the desired product is not amplified, repeat the PCR in step 1 with modified conditions (e.g. decreased Tm, increased MgSO4 or addition of DMSO). 12. Centrifuge 2 min at 10,000 x g in microcentrifuge.
13. Remove the M-IV medium containing glycerol and resuspend the bacteria in 1 ml M-IV medium.
14. Add target DNA and incubate 100 min. shaking with 100 rpm at 37 °C.
15. Centrifuge 2 min at 10,000 x g in microcentrifuge.
16. Remove 900 μl M-IV medium and plate 100 μl on selective BHI plates. Grow overnight at 37 °C + 5% CO2. 28. Pick a single colony from each plate using a loop and streak them independently onto new (selective) BHI plates. Grow them overnight at 37 °C + 5% CO2.
Note: From now on this protocol is identical for the wild type and mutant strains.
29. Resuspend colonies from step 28 in 5 ml of BHI medium with or without antibiotics.
30. Grow bacteria until OD 0.2 at 620 nm and place on ice.
31. Pipet 1.0 ml into a cryotube with 0.25 ml 80% glycerol and store at -80 °C.
32. Use of the remaining media for chromosomal DNA isolation.
33. Perform a chromosomal DNA isolation on the 5 ml culture from step 19 (e.g. CTAB protocol, for protocol see Notes below).
34. Perform two control PCRs with isolated genomic DNA from step 33 with similar conditions as in step 21 to confirm the deletion of the target gene and the insertion of the antibiotic resistance cassette. Include as negative control the chromosomal DNA of the wild type strain.
35. Load 2 μl PCR product mixed with DNA loading buffer on a 1.5% agarose gel with a 100 bp DNA marker.
36. Check the gel for the size of the PCR product and select a mutant to continue with.
Primer L1 + primer C (gene) should not result in an amplified PCR product, whereas the primer L1 + primer A (cassette) should give a PCR product. Select the correct mutant and throw away all others.
Notes
A. Generation of M-IV competent NTHi (for details see Reference 2)
